# A2 Biotherapeutics, Inc.: Research, Agoura Hills, United States

> A2 Biotherapeutics, Inc.: A2 Biotherapeutics, Inc. Based in Agoura Hills, United States. Founded 2018.

Source: https://millionrounds.com/startup/a2-biotherapeutics-inc (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# A2 Biotherapeutics, Inc.

A2 Biotherapeutics, Inc.

Funding reported Last round: Series B

Research Agoura Hills, United States

Company summary

- **Founded:** 2018 8 years old
- **Team:** 200 51 to 200 people
- **Funding reported:** $191M in dollars
- **Last round:** Series B Dec 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for A2 Biotherapeutics, Inc. has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About A2 Biotherapeutics, Inc.

A2 Biotherapeutics, Inc.

is a clinical-stage biotechnology company based in Agoura Hills, California, founded in 2018. The company is focused on developing precision CAR T-cell therapies for solid tumors using its proprietary TmodTM cell engineering platform. This innovative technology enables T cells to selectively target tumor cells while sparing normal cells, addressing a significant challenge in cancer treatment. The company is advancing a pipeline of first-in-class logic-gated cell therapies aimed at treating various solid tumors, including pancreatic, lung, colorectal, ovarian, and mesothelioma cancers. A2 Biotherapeutics operates within the oncology sector, serving cancer patients globally through a business-to-business model that delivers its therapies via healthcare systems and oncology clinics. With a strong foundation in both autologous and allogeneic applications, A2 Biotherapeutics is committed to restoring health and hope for individuals living with cancer and other serious diseases.

## What company datasets say A2 Biotherapeutics, Inc. raised

Funding, as reported

Reported in all **$191M** in dollars

Rounds **4**

Last round **Series B**

Last round size **$80M**

Last round date **Dec 2022**

Investors listed **8**

## Founders and team

From A2 Biotherapeutics, Inc.'s own website: 4 on the team.

- **James Robinson** President & Chief Executive Officer
- **Thomas Leung** Chief Financial Officer
- **Vikram Joshi** Chief Business Officer
- **Ryan Card** General Counsel

## On a portfolio page

Investors who name them

- [The Column Group](https://millionrounds.com/fund/the-column-group)

Each firm lists A2 Biotherapeutics, Inc. on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

research infrastructure hospital & health care research biological pathways health care tumor microenvironment tumor immunology companion diagnostic oncology cellular immunotherapy research and development targeting tumor microenvironment innovative therapies allogeneic cell therapy cancer immunology cgmp manufacturing

Built with from their website

Yoast Yoast SEO Google Maps CookieYes KnowBe4 123ContactForm Amazon SES WP Rocket Microsoft Email Providers CloudFlare CDN

+8 more

Google Tag Manager 123FormBuilder HTTP/3 Cloudflare Rocket Loader Google Maps (Non Paid Users) Amazon Simple Email Service OWL Carousel Bootstrap

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 2834, 8731
- **Region:** California
- **Revenue:** $33M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/a2-biotherapeutics)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put A2 Biotherapeutics, Inc. in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)